AI Medicine Software Market by Product Type and Application - Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 161 Category: Information & Communication Technology Report Code : IC0316961
AI Medicine Software Market By Product Type (Diagnosis Processes, Treatment Protocol Development, Drug Development) and Application (Hospital, Laboratory) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The AI Medicine Software Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. AI for medical imaging technologies offers machine learning capabilities in AI image analysis software, which allows training data to identify patterns and abnormalities that surpass the ability of human radiologists. Deep learning technologies are deployed to speed up this process and make it possible in real-time.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global AI Medicine Software Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Enlitic
- Atomwise
- DeepMind
- Babylon Health
- Flatiron Health
- Tempus Labs
- Sophia Genetics
- Recursion Pharmaceuticals
- Synyi
- Freenome
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o AI Medicine Software Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Diagnosis Processes
o Treatment Protocol Development
o Drug Development
o AI Medicine Software Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Laboratory
o AI Medicine Software Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Enlitic
o Atomwise
o DeepMind
o Babylon Health
o Flatiron Health
o Tempus Labs
o Sophia Genetics
o Recursion Pharmaceuticals
o Synyi
o Freenome
o AI Medicine Software Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America AI Medicine Software Market, By Country
o U.S. AI Medicine Software Market
o Canada AI Medicine Software Market
o Mexico AI Medicine Software Market
o Europe
§ Europe AI Medicine Software Market, By Country
o Germany AI Medicine Software Market
o UK AI Medicine Software Market
o France AI Medicine Software Market
o Russia AI Medicine Software Market
o Italy AI Medicine Software Market
o Rest of Europe AI Medicine Software Market
o Asia-Pacific
§ Asia-Pacific AI Medicine Software Market, By Country
o China AI Medicine Software Market
o Japan AI Medicine Software Market
o South Korea AI Medicine Software Market
o India AI Medicine Software Market
o Southeast Asia AI Medicine Software Market
o Rest of Asia-Pacific AI Medicine Software Market
o South America
§ South America AI Medicine Software Market
o Brazil AI Medicine Software Market
o Argentina AI Medicine Software Market
o Columbia AI Medicine Software Market
o Rest of South America AI Medicine Software Market
o Middle East and Africa
§ Middle East and Africa AI Medicine Software Market
o Saudi Arabia AI Medicine Software Market
o UAE AI Medicine Software Market
o Egypt AI Medicine Software Market
o Nigeria AI Medicine Software Market
o South Africa AI Medicine Software Market
o Rest of MEA AI Medicine Software Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. AI Medicine Software Market, By Product Type
5.1. Introduction
5.2. Global AI Medicine Software Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global AI Medicine Software Revenue and Revenue Share by Product Type (2017-2021)
5.3. Diagnosis Processes
5.3.1. Global Diagnosis Processes Revenue and Growth Rate (2017-2021)
5.4. Treatment Protocol Development
5.4.1. Global Treatment Protocol Development Revenue and Growth Rate (2017-2021)
5.5. Drug Development
5.5.1. Global Drug Development Revenue and Growth Rate (2017-2021)
6. AI Medicine Software Market, By Application
6.1. Introduction
6.2. Global AI Medicine Software Revenue and Market Share by Application (2017-2021)
6.2.1. Global AI Medicine Software Revenue and Revenue Share by Application (2017-2021)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2021)
6.4. Laboratory
6.4.1. Global Laboratory Revenue and Growth Rate (2017-2021)
7. AI Medicine Software Market, By Region
7.1. Introduction
7.2. Global AI Medicine Software Revenue and Market Share by Regions
7.2.1. Global AI Medicine Software Revenue by Regions (2017-2021)
7.3. North America AI Medicine Software by Countries
7.3.1. North America AI Medicine Software Revenue and Growth Rate (2017-2021)
7.3.2. North America AI Medicine Software Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe AI Medicine Software by Countries
7.4.1. Europe AI Medicine Software Revenue and Growth Rate (2017-2021)
7.4.2. Europe AI Medicine Software Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific AI Medicine Software by Countries
7.5.1. Asia-Pacific AI Medicine Software Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific AI Medicine Software Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America AI Medicine Software by Countries
7.6.1. South America AI Medicine Software Revenue and Growth Rate (2017-2021)
7.6.2. South America AI Medicine Software Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa AI Medicine Software by Countries
7.7.1. Middle East and Africa AI Medicine Software Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa AI Medicine Software Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Enlitic
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Atomwise
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. DeepMind
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Babylon Health
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Flatiron Health
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Tempus Labs
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Sophia Genetics
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Recursion Pharmaceuticals
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Synyi
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Freenome
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. AI Medicine Software Market Forecast (2022-2027)
9.1. Global AI Medicine Software Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. AI Medicine Software Market Forecast by Regions (2022-2027)
9.2.1. North America AI Medicine Software Market Forecast (2022-2027)
9.2.1.1. United States AI Medicine Software Market Forecast (2022-2027)
9.2.1.2. Canada AI Medicine Software Market Forecast (2022-2027)
9.2.1.3. Mexico AI Medicine Software Market Forecast (2022-2027)
9.2.2. Europe AI Medicine Software Market Forecast (2022-2027)
9.2.2.1. Germany AI Medicine Software Market Forecast (2022-2027)
9.2.2.2. France AI Medicine Software Market Forecast (2022-2027)
9.2.2.3. UK AI Medicine Software Market Forecast (2022-2027)
9.2.2.4. Russia AI Medicine Software Market Forecast (2022-2027)
9.2.2.5. Italy AI Medicine Software Market Forecast (2022-2027)
9.2.2.6. Rest of Europe AI Medicine Software Market Forecast (2022-2027)
9.2.3. Asia-Pacific AI Medicine Software Market Forecast (2022-2027)
9.2.3.1. China AI Medicine Software Market Forecast (2022-2027)
9.2.3.2. Japan AI Medicine Software Market Forecast (2022-2027)
9.2.3.3. Korea AI Medicine Software Market Forecast (2022-2027)
9.2.3.4. India AI Medicine Software Market Forecast (2022-2027)
9.2.3.5. Southeast Asia AI Medicine Software Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific AI Medicine Software Market Forecast (2022-2027)
9.2.4. South America AI Medicine Software Market Forecast (2022-2027)
9.2.4.1. Brazil AI Medicine Software Market Forecast (2022-2027)
9.2.4.2. Argentina AI Medicine Software Market Forecast (2022-2027)
9.2.4.3. Columbia AI Medicine Software Market Forecast (2022-2027)
9.2.4.4. Rest of South America AI Medicine Software Market Forecast (2022-2027)
9.2.5. Middle East and Africa AI Medicine Software Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia AI Medicine Software Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates AI Medicine Software Market Forecast (2022-2027)
9.2.5.3. Egypt AI Medicine Software Market Forecast (2022-2027)
9.2.5.4. Nigeria AI Medicine Software Market Forecast (2022-2027)
9.2.5.5. South Africa AI Medicine Software Market Forecast (2022-2027)
9.2.5.6. Turkey AI Medicine Software Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa AI Medicine Software Market Forecast (2022-2027)
9.3. AI Medicine Software Market Forecast by Product Type (2022-2027)
9.3.1. AI Medicine Software Forecast by Product Type (2022-2027)
9.3.2. AI Medicine Software Market Share Forecast by Product Type (2022-2027)
9.4. AI Medicine Software Market Forecast by Application (2022-2027)
9.4.1. AI Medicine Software Forecast by Application (2022-2027)
9.4.2. AI Medicine Software Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure France AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure China AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure India AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa AI Medicine Software Revenue (Million USD) and Growth Rate (2017-2027)
Table Global AI Medicine Software Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Diagnosis Processes Revenue and Growth Rate (2017-2019)
Figure Global Treatment Protocol Development Revenue and Growth Rate (2017-2019)
Figure Global Drug Development Revenue and Growth Rate (2017-2019)
Table Global AI Medicine Software Revenue and Revenue Share by Application (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Laboratory Revenue and Growth Rate (2017-2019)
Table Global AI Medicine Software Revenue by Regions (2017-2019)
Figure North America AI Medicine Software Growth Rate (2017-2019)
Figure North America AI Medicine Software Revenue and Growth Rate (2017-2019)
Figure North America AI Medicine Software by Countries (2017-2019)
Figure North America AI Medicine Software Revenue (Million USD) by Countries (2017-2019)
Figure United States AI Medicine Software Growth Rate (2017-2019)
Figure United States AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada AI Medicine Software Growth Rate (2017-2019)
Figure Canada AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico AI Medicine Software Growth Rate (2017-2019)
Figure Mexico AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe AI Medicine Software Growth Rate (2017-2019)
Figure Europe AI Medicine Software Revenue and Growth Rate (2017-2019)
Figure Europe AI Medicine Software by Countries (2017-2019)
Figure Europe AI Medicine Software Revenue (Million USD) by Countries (2017-2019)
Figure Germany AI Medicine Software Growth Rate (2017-2019)
Figure Germany AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France AI Medicine Software Growth Rate (2017-2019)
Figure France AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK AI Medicine Software Growth Rate (2017-2019)
Figure UK AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia AI Medicine Software Growth Rate (2017-2019)
Figure Russia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy AI Medicine Software Growth Rate (2017-2019)
Figure Italy AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe AI Medicine Software Growth Rate (2017-2019)
Figure Rest of Europe AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific AI Medicine Software Growth Rate (2017-2019)
Figure Asia-Pacific AI Medicine Software Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific AI Medicine Software by Countries (2017-2019)
Figure Asia-Pacific AI Medicine Software Revenue (Million USD) by Countries (2017-2019)
Figure China AI Medicine Software Growth Rate (2017-2019)
Figure China AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan AI Medicine Software Growth Rate (2017-2019)
Figure Japan AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea AI Medicine Software Growth Rate (2017-2019)
Figure Korea AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India AI Medicine Software Growth Rate (2017-2019)
Figure India AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia AI Medicine Software Growth Rate (2017-2019)
Figure Southeast Asia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific AI Medicine Software Growth Rate (2017-2019)
Figure Rest of Asia-Pacific AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America AI Medicine Software Growth Rate (2017-2019)
Figure South America AI Medicine Software Revenue and Growth Rate (2017-2019)
Figure South America AI Medicine Software by Countries (2017-2019)
Figure South America AI Medicine Software Revenue (Million USD) by Countries (2017-2019)
Figure Brazil AI Medicine Software Growth Rate (2017-2019)
Figure Brazil AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina AI Medicine Software Growth Rate (2017-2019)
Figure Argentina AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia AI Medicine Software Growth Rate (2017-2019)
Figure Columbia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America AI Medicine Software Growth Rate (2017-2019)
Figure Rest of South America AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa AI Medicine Software Growth Rate (2017-2019)
Figure Middle East and Africa AI Medicine Software Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa AI Medicine Software by Countries (2017-2019)
Figure Middle East and Africa AI Medicine Software Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia AI Medicine Software Growth Rate (2017-2019)
Figure Saudi Arabia AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates AI Medicine Software Growth Rate (2017-2019)
Figure United Arab Emirates AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt AI Medicine Software Growth Rate (2017-2019)
Figure Egypt AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria AI Medicine Software Growth Rate (2017-2019)
Figure Nigeria AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa AI Medicine Software Growth Rate (2017-2019)
Figure South Africa AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey AI Medicine Software Growth Rate (2017-2019)
Figure Turkey AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa AI Medicine Software Growth Rate (2017-2019)
Figure Rest of Middle East and Africa AI Medicine Software Revenue (Millions USD) and Growth Rate (2017-2019)
Table Enlitic AI Medicine Software Financial Overview
Table Atomwise AI Medicine Software Financial Overview
Table DeepMind AI Medicine Software Financial Overview
Table Babylon Health AI Medicine Software Financial Overview
Table Flatiron Health AI Medicine Software Financial Overview
Table Tempus Labs AI Medicine Software Financial Overview
Table Sophia Genetics AI Medicine Software Financial Overview
Table Recursion Pharmaceuticals AI Medicine Software Financial Overview
Table Synyi AI Medicine Software Financial Overview
Table Freenome AI Medicine Software Financial Overview
Figure Global AI Medicine Software Revenue (Millions USD) and Growth Rate (2019-2027)
Table AI Medicine Software Market Forecast by Regions (2019-2027)
Figure North America AI Medicine Software Market Forecast (2019-2027)
Figure United States AI Medicine Software Market Forecast (2019-2027)
Figure Canada AI Medicine Software Market Forecast (2019-2027)
Figure Mexico AI Medicine Software Market Forecast (2019-2027)
Figure Europe AI Medicine Software Market Forecast (2019-2027)
Figure Germany AI Medicine Software Market Forecast (2019-2027)
Figure France AI Medicine Software Market Forecast (2019-2027)
Figure UK AI Medicine Software Market Forecast (2019-2027)
Figure Russia AI Medicine Software Market Forecast (2019-2027)
Figure Italy AI Medicine Software Market Forecast (2019-2027)
Figure Rest of Europe AI Medicine Software Market Forecast (2019-2027)
Figure Asia-Pacific AI Medicine Software Market Forecast (2019-2027)
Figure China AI Medicine Software Market Forecast (2019-2027)
Figure Japan AI Medicine Software Market Forecast (2019-2027)
Figure Korea AI Medicine Software Market Forecast (2019-2027)
Figure India AI Medicine Software Market Forecast (2019-2027)
Figure Southeast Asia AI Medicine Software Market Forecast (2019-2027)
Figure Rest of Asia-Pacific AI Medicine Software Market Forecast (2019-2027)
Figure South America AI Medicine Software Market Forecast (2019-2027)
Figure Brazil AI Medicine Software Market Forecast (2019-2027)
Figure Argentina AI Medicine Software Market Forecast (2019-2027)
Figure Columbia AI Medicine Software Market Forecast (2019-2027)
Figure Rest of South America AI Medicine Software Market Forecast (2019-2027)
Figure Middle East and Africa AI Medicine Software Market Forecast (2019-2027)
Figure Saudi Arabia AI Medicine Software Market Forecast (2019-2027)
Figure United Arab Emirates AI Medicine Software Market Forecast (2019-2027)
Figure Egypt AI Medicine Software Market Forecast (2019-2027)
Figure Nigeria AI Medicine Software Market Forecast (2019-2027)
Figure South Africa AI Medicine Software Market Forecast (2019-2027)
Figure Turkey AI Medicine Software Market Forecast (2019-2027)
Figure Rest of Middle East and Africa AI Medicine Software Market Forecast (2019-2027)
Figure Global AI Medicine Software Forecast by Product Type (2019-2027)
Figure Global AI Medicine Software Market Share Forecast by Product Type (2019-2027)
Figure Global AI Medicine Software Forecast by Product Type (2019-2027)
Figure Global AI Medicine Software Forecast by Application (2019-2027)
Figure Global AI Medicine Software Market Share Forecast by Application (2019-2027)
Figure Global AI Medicine Software Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|